Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Bluejay Diagnostics Inc. Common Stock
BJDX | US
4.34
USD2.17
100.00%
BJDX | US
Loading StockChartView...
About Bluejay Diagnostics Inc. Common Stock
Sector
Healthcare
Industry
Medical Devices
Earnings date
30/06/2024
As of date
02/06/2026
Close
4.34
Open
6.12
High
7.00
Low
3.71
Bluejay Diagnostics Inc. a medical diagnostic company develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform a technology platform comprising Symphony analyzer that orchestrates blood processing biomarker isolation and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge which includes reagents and components. The company also offers ALLEREYE diagnostic test a point-of-care device for the diagnosis of allergic conjunctivitis. In addition it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton Massachusetts.
View LessBJDX | US
Risk
350.2
Sharpe
-0.22
Luna's Score
57/100
Recommendation
Hold
Luna says (BJDX | US)
What's Working
Strength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
493.7%1 month
350.2%3 months
208.1%6 months
165.4%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.18
Debt to equity
0.05
Debt to assets
0.04
Ent. to EBITDA
-0.10
Ent. to rev.
5.67
PEG
-
Other Fundamentals
EBITDA
-8.74M
MarketCap
71.82M
MarketCap(USD)
71.82M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-125.25
Short ratio
0.04
Short perc.
0.24
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
5.38
Range1M
5.38
Range3M
5.38
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
20.59
Price X volume
321.09M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.10 | 46.09 | Cheaper |
| Ent. to Revenue | 5.67 | 14.34 | Cheaper |
| PE Ratio | - | 30.41 | - |
| Price to Book | 0.18 | 6.21 | Cheaper |
| Dividend Yield | - | 1.78 | - |
| Std. Deviation (3M) | 208.12 | 64.12 | Riskier |
| Debt to Equity | 0.05 | -145.53 | Expensive |
| Debt to Assets | 0.04 | 0.35 | Cheaper |
| Market Cap | 71.82M | 9.70B | Emerging |
